Stock listing
NASDAQ:NEOS Neos Therapeutics Inc Stock
Follow Neos Therapeutics Inc into a list and get an email when it puts out news.
Last close · NASDAQ:NEOS
$1.15 USD
Close on Mar 19, 2021 · No longer trades
- Lowest – highest close
- $0.466 – $27.09 USDSince Jul 22, 2015 · lowest Oct 16, 2020 · highest Aug 28, 2015
Delisted NASDAQ:NEOS no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:NEOS
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Neos Therapeutics Inc on 6ix
- Decks
- 1 deck · latest Dec 11, 2020
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Merger or Acquisition (December 2020) | Merger or acquisition | 19 slides | Dec 11, 2020 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| John Schmid Other companies: BlossomHill Therapeutics, Inc. (Board Member · Since at least Aug 6, 2026); First Tracks Biotherapeutics, Inc. (Director · Since at least Apr 1, 2026); Helix Acquisition Corp. III (Director · Since at least Jan 22, 2026); Design Therapeutics, Inc. (Director · Since at least Mar 25, 2021); AnaptysBio, Inc. (Director · Since at least Feb 2, 2018); BridgeBio Oncology Therapeutics, Inc. (Director · Feb 8, 2024 – Feb 8, 2024 · Past); Xeris Biopharma Holdings, Inc. (Director · Oct 5, 2021 – Aug 12, 2024 · Past); MoonLake Immunotherapeutics (Director · Oct 19, 2020 – Oct 19, 2020 · Past); Poseida Therapeutics Inc (Director · Jul 9, 2020 – Jan 8, 2025 · Past) | Director · Jul 2, 2018 – Mar 19, 2021 · Past |
| Paul Edick Other companies: Vistagen Therapeutics, Inc. (Director · Since at least Oct 27, 2025); Xeris Biopharma Holdings, Inc. (See Remarks, Director · Oct 5, 2021 – Jan 31, 2024 · Past); Milestone Pharmaceuticals Inc. (Director · May 8, 2019 – Jun 5, 2020 · Past); Sucampo Pharmaceuticals Inc (Director · Aug 1, 2016 – Feb 13, 2018 · Past); PDL BioPharma Inc (Director · Sep 3, 2015 – Jun 8, 2018 · Past); Durata Therapeutics Inc (Chief Executive Officer, Director · Mar 15, 2012 – Nov 17, 2014 · Past); Lumos Pharma Inc (Director · Nov 10, 2011 – May 12, 2017 · Past) | Director · Jul 22, 2015 – Jul 3, 2017 · Past |
| Gerald W McLaughlin Other companies: Allarity Therapeutics, Inc. (Director · Since at least Oct 1, 2022); Aytu BioPharma, Inc. (Director · Mar 19, 2021 – Apr 8, 2021 · Past); Skye Bioscience, Inc. (Director · Oct 31, 2014 – Oct 20, 2015 · Past); NuPathe Inc. (SVP, Chief Commercial Officer · Aug 5, 2010 – Feb 21, 2014 · Past) | Chief Executive Officer, Director · Jun 27, 2018 – Mar 19, 2021 · Past |
| James A Robinson Jr Other companies: Eledon Pharmaceuticals, Inc. (Director · Since at least Oct 1, 2023); UroGen Pharma Ltd. (Director · Since at least Jul 25, 2023); Urovant Sciences Ltd (PEO;CEO/Urovant Sciences, Inc., Director · Mar 1, 2019 – Mar 29, 2021 · Past); Alkermes plc (President & COO,Alkermes, Inc. · Mar 5, 2018 – Apr 4, 2019 · Past) | Director · Jan 29, 2019 – Mar 19, 2021 · Past |
| Richard I Eisenstadt Other companies: Altimmune, Inc. (Chief Financial Officer · Dec 31, 2021 – Jan 30, 2024 · Past); Aytu BioPharma, Inc. (Chief Financial Officer · Mar 31, 2021 – Mar 31, 2021 · Past); Ocera Therapeutics Inc (VP, Finance & CFO · Apr 1, 2011 – Aug 7, 2012 · Past) | Chief Financial Officer · Jul 22, 2015 – Mar 19, 2021 · Past |
| Alan L Heller Other companies: Savient Pharmaceuticals Inc (Director · May 23, 2006 – Sep 15, 2011 · Past); Northfield Laboratories Inc (Director · Feb 18, 2006 – Jan 2, 2009 · Past) | Director · Jul 22, 2015 – Mar 19, 2021 · Past |
| Beth Hecht Other companies: Xeris Biopharma Holdings, Inc. (See Remarks · Since at least Oct 5, 2021); Aytu BioPharma, Inc. (Director · Mar 19, 2021 – Apr 8, 2021 · Past) | Director · Sep 1, 2015 – Mar 19, 2021 · Past |
| Bryant Fong Other companies: TruGolf Holdings, Inc. (Director · Oct 26, 2021 – Oct 26, 2021 · Past); ADMA Biologics Inc (Director · Feb 13, 2012 – Feb 26, 2024 · Past) | Director · Jul 22, 2015 – Mar 19, 2021 · Past |
| Vipin K Garg Other companies: Altimmune, Inc. (Director · Since at least Nov 30, 2018); Ocera Therapeutics Inc (President & CEO, Director · Apr 1, 2011 – Aug 7, 2012 · Past) | Chief Executive Officer · Jul 22, 2015 – Mar 1, 2018 · Past |
| John M Limongelli Other companies: Trevena, Inc. (Sr. VP,General Counsel & CAO · Feb 28, 2018 – Feb 28, 2018 · Past) | SVP & General Counsel · Mar 20, 2019 – Mar 19, 2021 · Past |
All 15 people
| Person | Seat |
|---|---|
| Linda Szyper Other companies: Harmony Biosciences Holdings, Inc. (Director · Since at least Nov 18, 2021) | Director · Apr 27, 2018 – Mar 19, 2021 · Past |
| Dorothy Engelking | VP, Regulatory Affairs · Jul 22, 2015 – Mar 1, 2018 · Past |
| Gregory J Robitaille | Director · Jul 22, 2015 – Mar 19, 2021 · Past |
| Mark Tengler | Chief Technology Officer · Jul 22, 2015 – Sep 1, 2015 · Past |
| Thomas P McDonnell | Chief Commercial Officer · Jul 22, 2015 – May 1, 2018 · Past |
Log in to ask 6ix AI your own questions about Neos Therapeutics Inc.